ADAGIO THERAPEUTICS

Adagio is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antibodies has been optimized using Adimab’s industry-leading antibody engineering capabilities and is designed to provide patients and clinicians with a powerful combination of potency, breadth, durable protection (via half-life extension), manufacturability and affordability. ... Adagio’s portfolio of SARS-CoV-2 antibodies includes multiple, non-competing broadly neutralizing antibodies with distinct binding epitopes, led by ADG20. Adagio has secured manufacturing capacity for the production of ADG20 with thirdparty contract manufacturers through the completion of clinical trials and, if approved by regulatory authorities, through initial commercial launch.

#SimilarOrganizations #People #Financial #Event #Website #More

ADAGIO THERAPEUTICS

Social Links:

Linkedin

Twitter

Industry:

Biotechnology Pharmaceutical Therapeutics

Founded:

2020-01-01

Address:

Waltham, Massachusetts, United States

Country:

United States

Website Url:

http://www.adagiotx.com

Total Employee:

51+

Status:

Active

Contact:

781-819-0080

Email Addresses:

[email protected]

Total Funding:

466 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Wordpress Plugins Mobile Non Scaleable Content Microsoft Exchange Online

Similar Organizations

click-therapeutics-logo

Click Therapeutics

Click Therapeutics delivers safe and effective digital treatments to patients in need.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

Current Advisors List

ajay-gopal-royan_image

Ajay Gopal Royan Board Member @ Adagio Therapeutics
Board_member
2020-07-01

terrance-mcguire_image

Terrance McGuire Board Member @ Adagio Therapeutics
Board_member
2020-07-01

philip-chase_image

Philip Chase Board Member @ Adagio Therapeutics
Board_member
2020-07-01

not_available_image

Marc Elia Board Member @ Adagio Therapeutics
Board_member
2020-07-01

Current Employees Featured

tillman-gerngross_image

Tillman Gerngross
Tillman Gerngross Co-Founder and CEO @ Adagio Therapeutics
Co-Founder and CEO

eric-kimble_image

Eric Kimble
Eric Kimble CCO @ Adagio Therapeutics
CCO

ellie-hershberger_image

Ellie Hershberger
Ellie Hershberger CDO @ Adagio Therapeutics
CDO

lynn-connolly_image

Lynn Connolly
Lynn Connolly CMO @ Adagio Therapeutics
CMO

not_available_image

Lawrence Beck
Lawrence Beck Vice President of Finance @ Adagio Therapeutics
Vice President of Finance

halley-gilbert_image

HALLEY GILBERT
HALLEY GILBERT COO & CBO @ Adagio Therapeutics
COO & CBO

not_available_image

Michele Crosby
Michele Crosby Head of Legal & HR Operations @ Adagio Therapeutics
Head of Legal & HR Operations

rebecca-dabora_image

Rebecca Dabora
Rebecca Dabora Chief Technology & Manufacturing Officer @ Adagio Therapeutics
Chief Technology & Manufacturing Officer

david-hering_image

David Hering
David Hering CEO @ Adagio Therapeutics
CEO
2021-07-01

jane-pritchett-henderson_image

Jane Pritchett Henderson
Jane Pritchett Henderson Chief Financial Officer @ Adagio Therapeutics
Chief Financial Officer
2020-12-01

Founder

laura-walker_image

Laura Walker

tillman-gerngross_image

Tillman Gerngross

Stock Details

Company's stock symbol is NASDAQ:ADGI

Investors List

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series C - Adagio Therapeutics

population-health-partners_image

Population Health Partners

Population Health Partners investment in Series C - Adagio Therapeutics

adimab_image

Adimab

Adimab investment in Series C - Adagio Therapeutics

mithril-capital-management_image

Mithril Capital Management

Mithril Capital Management investment in Series C - Adagio Therapeutics

google-ventures_image

GV

GV investment in Series C - Adagio Therapeutics

fidelity-management-and-research-company_image

Fidelity Management and Research Company

Fidelity Management and Research Company investment in Series C - Adagio Therapeutics

redmile-group_image

Redmile Group

Redmile Group investment in Series C - Adagio Therapeutics

foresite-capital_image

Foresite Capital

Foresite Capital investment in Series C - Adagio Therapeutics

polaris-partners_image

Polaris Partners

Polaris Partners investment in Series C - Adagio Therapeutics

arrowpoint-partners_image

ArrowMark Partners

ArrowMark Partners investment in Series C - Adagio Therapeutics

Key Employee Changes

Date	New article
2021-07-19	Adagio Therapeutics Appoints David Hering, Global COVID-19 Vaccine Expert, as Chief Operating Officer

Official Site Inspections

http://www.adagiotx.com Semrush global rank: 3.47 M Semrush visits lastest month: 4.37 K

Host Informations
Whois Informations

Loading ...

More informations about "Adagio Therapeutics" on Search Engine